Karakolevska Ilova, Marija (2017) Treatment of HR positive, HER 2 negative metastatic breast cancer in premenopausal women. In: 4th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, Belgrade, RSerbia. (Unpublished)
![[thumbnail of Presentation Masterclass Belgrade 2017.pdf]](/style/images/fileicons/image.png) |
Image
Presentation Masterclass Belgrade 2017.pdf - Presentation Download (207kB) |
![[thumbnail of programa Belgrad 2017.pdf]](/style/images/fileicons/text.png) |
Text
programa Belgrad 2017.pdf Download (307kB) |
Abstract
Although hormonal-therapy is the preferred first-line treatment for hormone-responsive, HER2 negative metastatic breast cancer, no data from clinical trials support the choice between hormonal-therapy and chemotherapy. The dilemma for the treatment of these patients is derived from the site of metastasis and size of metastases as well as whether they are premenopausal or postmenopausal patients. There are very few studies that confirm the best choice of treatment for premenopausal patients with hormone-dependent metastatic disease.
| Item Type: | Conference or Workshop Item (Speech) |
|---|---|
| Uncontrolled Keywords: | HR positive HER2 negative breast cancer, metastatic breast cancer, premenopausal women |
| Subjects: | Medical and Health Sciences > Clinical medicine |
| Divisions: | Faculty of Medical Science |
| Depositing User: | Marija Karakolevska |
| Date Deposited: | 03 May 2022 10:16 |
| Last Modified: | 03 May 2022 10:16 |
| URI: | https://eprints.ugd.edu.mk/id/eprint/29650 |
Actions (login required)
 |
View Item |